REGENXBIO Shares Jump on Promising Duchenne Gene Therapy Results
REGENXBIO stock rises 8% after positive 18-month trial data for RGX-202, its one-time gene therapy treating Duchenne muscular dystrophy in boys.
NOTRELOAD AI
Tempus AI Hits Major Milestone with $1.1 Billion in Contracts
Tempus AI achieves record $1.1 billion in total contract value, partners with 70+ pharmaceutical companies, and reports 31% revenue growth in 2025.
Morgan Stanley Upgrades Akamai, Sees Growth Ahead
Morgan Stanley upgrades Akamai to Overweight, raising its price target to $115 as growth prospects improve across cloud, security, and compute services.
Trump's 10% Credit Card Rate Cap Shakes Banking Stocks
Financial stocks plunge as Trump proposes 10% credit card interest rate cap. Banks and card issuers face potential profitability concerns under new affordability measure.
Walmart Joins Nasdaq-100 Index; Stock Rises
Walmart stock surges 3.5% in premarket trading as the retail giant prepares to join the Nasdaq-100 index on January 20, 2026, following strong annual growth.
Xpeng's Flying Car Unit Aeroht Plans Hong Kong IPO This Year
Chinese EV maker Xpeng hires JPMorgan and Morgan Stanley for Aeroht flying car IPO in Hong Kong, targeting China's growing low-altitude economy market.